Galliprant (grapiprant tablets) is a non-steroidal, anti-inflammatory drug for the control of pain and inflammation due to osteoarthritis in dogs. It is specifically formulated to safely treat canine osteoarthritis (OA) from its earliest diagnosed stages. In fact, dogs as young as 9 months of age have been safely treated with Galliprant (grapiprant tablets) for early stages of osteoarthritis. Galliprant (grapiprant tablets) is a new class of anti-inflammatory that targets pain and helps dogs with OA remain comfortable and active. It specifically blocks the primary mediator of canine OA pain and inflammation (EP4 receptor) while reducing the impact on gastrointestinal, kidney, and liver homeostasis. The pork liver-flavored tablets are scored for easy administration. Galliprant (grapiprant tablets) requires a prescription from your veterinarian.
Dogs (9+ months of age, weighing 3.5+ kg )
Galliprant (grapiprant tablets) is a first-in-class non-COX-inhibiting prostaglandin receptor antagonist. It specifically blocks the EP4 receptor, the primary mediator of canine osteoarthritis pain and inflammation. Galliprant (grapiprant tablets) does not inhibit the production of many housekeeping prostanoids that maintain homeostatic functions.
Galliprant (grapiprant tablets) is for use in dogs 9 months of age or older, weighing 3.5kg or more only. Do not use in cats. Galliprant (grapiprant tablets) are not for use in humans. Keep this and all medications out of reach of children and pets. Consult a physician in case of accidental ingestion by humans. Store Galliprant (grapiprant tablets) out of reach of dogs and other pets in a secured location in order to prevent accidental ingestion or overdose.
Galliprant (grapiprant tablets)
Grapiprant
Galliprant (grapiprant tablets) is used in dogs for the treatment of pain and inflammation from osteoarthritis (OA). It is a first-in-class non-COX-inhibiting prostaglandin receptor antagonist. Galliprant (grapiprant tablets) is prescription (RX) medication. It is available in 20 mg, 60 mg, and 100 mg strength tablets. The safe use of Galliprant (grapiprant tablets) has not been evaluated in dogs younger than 9 months of age and less than 8 lbs in weight, dogs used for breeding, or in pregnant or lactating dogs. Galliprant (grapiprant tablets) should not be used in dogs that have a hypersensitivity to grapiprant. If Galliprant (grapiprant tablets) is used long term, appropriate monitoring is recommended. Concurrent use with other anti-inflammatory drugs has not been studied. Concomitant use of Galliprant (grapiprant tablets) with other anti-inflammatory drugs, such as COX-inhibiting NSAIDs or corticosteroids, should be avoided. If additional pain medication is needed after a daily dose of Galliprant (grapiprant tablets), a non-NSAID/non-corticosteroid class of analgesic may be necessary. Concomitant use of protein-bound drugs with Galliprant (grapiprant tablets) has not been studied. Commonly used protein-bound drugs include cardiac, anticonvulsant and behavioral medications. Drug compatibility should be monitored in patients requiring adjunctive therapy. Consider appropriate washout times when switching from one anti-inflammatory to another or when switching from corticosteroids or COX-inhibiting NSAIDs to Galliprant (grapiprant tablets) use. The use of Galliprant (grapiprant tablets) in dogs with cardiac disease has not been studied. It is not known whether dogs with a history of hypersensitivity to sulfonamide drugs will exhibit hypersensitivity to Galliprant (grapiprant tablets). Galliprant (grapiprant tablets) is a methylbenzenesulfonamide. See Galliprant label for complete safety information.
Tell your veterinarian if your dog has a history of cardiac disease, is used for breeding, or is pregnant or lactating. Also tell your veterinarian if your pet is currently on other anti-inflammatory drugs, such as COX-inhibiting NSAIDs or corticosteroids. Also inform your veterinarian of any side effects your dog has experienced from Galliprant (grapiprant tablets) or other NSAIDs; digestive issues (bloody, mucoid stool, vomiting or diarrhea, or decreased appetite) your dog has; any other medical problems or allergies that your dog has had.
The dose of Galliprant (grapiprant tablets) is 2 mg/kg once daily. Use the lowest effective dose for the shortest duration consistent with individual response.
Adverse reactions in dogs receiving Galliprant (grapiprant tablets) may include vomiting, diarrhea, decreased appetite, and tiredness.
If you miss giving a dose of Galliprant (grapiprant tablets), contact your veterinarian. Do not double dose.
Contact your veterinarian or veterinary emergency room.
Avoid giving other medications to your pet while on Galliprant (grapiprant tablets) unless approved by your veterinarian. Do not give to cats or dogs weighing less than 3.5 kg.
Galliprant (grapiprant tablets) should not be given with other non-steroidal anti-inflammatory drugs (NSAIDs) or corticosteroids (for example, aspirin, carprofen, meloxicam and prednisone).
More detail about Hanavet Sdn Bhd
Malaysia
